Intact N-Terminal Propeptide of Type 1 Procollagen
Familial Mediterranean Fever (MEFV) Gene Mutation Analysis
Polyoma BK virus infections
Chronic osteomyelitis
Malignant neoplasm, uterine cervix (cervical cancer)
Croup
Measles, Mumps, Rubella, and Varicella-zoster Viruses (MMRV) Immune Status Profile
Synovial Fluid Analysis
Recurrent pregnancy loss (Miscarriage)
Epidermal Growth Factor Receptor (EGFR), IHC
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Interpretation
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now
Loading...